22.94
-1.38
(-5.67%)
At close: January 14 at 4:00:01 PM EST
22.96
+0.02
+(0.09%)
After hours: January 14 at 5:30:49 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-157,835.00
-107,291.00
-103,732.00
-60,909.00
-40,404.00
Investing Cash Flow
-485,337.00
-105,782.00
89,942.00
-216,156.00
-98,218.00
Financing Cash Flow
658,437.00
218,458.00
4,076.00
272,372.00
171,226.00
End Cash Position
36,399.00
34,814.00
29,429.00
39,143.00
43,836.00
Capital Expenditure
-1,829.00
-1,818.00
-1,828.00
-1,249.00
-1,552.00
Issuance of Capital Stock
648,520.00
216,222.00
--
269,893.00
170,792.00
Issuance of Debt
--
--
--
--
2,962.00
Repayment of Debt
--
--
--
--
-2,962.00
Free Cash Flow
-159,664.00
-109,109.00
-105,560.00
-62,158.00
-41,956.00
12/31/2020 - 5/15/1986
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
JSPR Jasper Therapeutics, Inc.
5.87
-12.26%
STOK Stoke Therapeutics, Inc.
8.68
-2.69%
DYN Dyne Therapeutics, Inc.
15.00
-1.90%
VRDN Viridian Therapeutics, Inc.
16.86
-5.12%
INZY Inozyme Pharma, Inc.
1.5100
-12.21%
AKRO Akero Therapeutics, Inc.
21.87
-3.36%
MIRM Mirum Pharmaceuticals, Inc.
43.32
-1.55%
THRD Third Harmonic Bio, Inc.
5.99
-8.13%
RLAY Relay Therapeutics, Inc.
4.3450
-9.10%
JANX Janux Therapeutics, Inc.
45.35
+0.64%